Compare COGT & OPLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COGT | OPLN |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.6B |
| IPO Year | 2018 | 2008 |
| Metric | COGT | OPLN |
|---|---|---|
| Price | $27.46 | $34.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 9 |
| Target Price | ★ $55.82 | $45.11 |
| AVG Volume (30 Days) | ★ 2.0M | 936.3K |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.02 |
| Revenue | $7,871,000.00 | ★ $1,934,500,000.00 |
| Revenue This Year | N/A | $13.17 |
| Revenue Next Year | $5,819.52 | $8.60 |
| P/E Ratio | ★ N/A | $34.34 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $27.74 | $25.81 |
| 52 Week High | $43.73 | $42.69 |
| Indicator | COGT | OPLN |
|---|---|---|
| Relative Strength Index (RSI) | 37.79 | 38.84 |
| Support Level | N/A | $33.92 |
| Resistance Level | $37.34 | $35.91 |
| Average True Range (ATR) | 1.81 | 1.14 |
| MACD | -0.30 | -0.39 |
| Stochastic Oscillator | 4.41 | 7.99 |
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
Openlane Inc provides a digital marketplace for used vehicles, connecting sellers and buyers in North America and Europe for fast and transparent transactions. Its services include financing, repossessions, repairs, transportation, warranty, and inventory management. The company operates used-vehicle auctions and has two main segments: Marketplace and Finance, with majority revenue coming from the Marketplace segment, which to used vehicle remarketing, including marketplace services, remarketing, or make ready services and all are interrelated, synergistic elements along the auto remarketing chain. The Finance segment, through AFC engaged in business of providing short-term, inventory-secured financing to independent vehicle dealers.